ClinicalTrials.Veeva

Menu
F

FAICIC Clinical Research | Veracruz, Mexico

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
Ritonavir
PF-07321332
MK-3475-630
Gemcitabine
paclitaxel
Afimkibart

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 7 total trials

A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease (SIBERITE-PEDS)

This phase III, double-blind, multi-center treat-through study will evaluate the efficacy and safety of Afimkibart (also known as RO7790121) in child...

Enrolling
Moderately to Severely Active Crohns Disease
Drug: Afimkibart

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Pfizer logo
Incyte logo
NovoCure logo
Roche logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems